WUXI BIOLOGICS CAYMAN INC ADR's ticker is WXXWY and the CUSIP is 98260N108. A total of 5 filers reported holding WUXI BIOLOGICS CAYMAN INC ADR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,357,344 | -26.7% | 245,988 | -5.3% | 0.49% | -27.7% |
| Q1 2023 | $3,215,421 | -19.0% | 259,681 | +0.4% | 0.68% | -22.2% |
| Q4 2022 | $3,967,455 | +25.1% | 258,696 | -1.6% | 0.87% | +17.5% |
| Q3 2022 | $3,172,000 | -37.6% | 262,854 | -5.4% | 0.74% | -27.2% |
| Q2 2022 | $5,085,000 | +54.7% | 277,944 | +39.4% | 1.02% | +85.1% |
| Q1 2022 | $3,286,000 | -17.0% | 199,360 | +19.3% | 0.55% | -11.8% |
| Q4 2021 | $3,957,000 | -32.6% | 167,063 | -7.5% | 0.62% | -26.7% |
| Q3 2021 | $5,869,000 | -23.8% | 180,580 | -14.1% | 0.85% | -19.3% |
| Q2 2021 | $7,705,000 | -2.5% | 210,122 | -33.3% | 1.06% | -10.0% |
| Q1 2021 | $7,906,000 | +0.1% | 314,845 | +5.5% | 1.18% | -4.9% |
| Q4 2020 | $7,901,000 | +65.6% | 298,334 | +204.7% | 1.24% | +40.0% |
| Q3 2020 | $4,772,000 | +26.2% | 97,904 | -5.2% | 0.88% | +17.8% |
| Q2 2020 | $3,780,000 | +244.3% | 103,328 | +143.9% | 0.75% | +207.0% |
| Q1 2020 | $1,098,000 | – | 42,357 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMAS WHITE INTERNATIONAL LTD | 167,063 | $3,957,000 | 0.62% |
| EQUITABLE TRUST CO | 149,389 | $3,547,000 | 0.22% |
| SkyView Investment Advisors, LLC | 1,289 | $356,000 | 0.08% |
| MayTech Global Investments, LLC | 6,871 | $161,000 | 0.03% |
| SENTINEL TRUST CO LBA | 8,545 | $203,000 | 0.02% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 29,491 | $691,000 | 0.01% |
| MAI Capital Management | 22,962 | $538,000 | 0.01% |
| SVB WEALTH LLC | 15,372 | $360,000 | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 24,999 | $586,000 | 0.00% |
| First Horizon Advisors, Inc. | 2,501 | $58,000 | 0.00% |